Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8703)
All Articles published online
|
Publishing Process of This Article
|
Mar 27, 2024 (publication date) through Feb 9, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Lam R, Lim JK. Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agents. World J Hepatol 2024; 16(3): 331-343 [PMID: 38577537 DOI: 10.4254/wjh.v16.i3.331] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Lam R, Lim JK. Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agents. World J Hepatol 2024; 16(3): 331-343 [PMID: 38577537 DOI: 10.4254/wjh.v16.i3.331] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i3/331.htm |
| Number | Citing Articles |
| 1 |
Ramakrishnamraju Samunuri, Masaaki Toyama, Mohan Kasula, Ashok Kumar Jha, Mika Okamoto, Masanori Baba, Ashoke Sharon. Synthesis, Cytotoxicity, and Mechanistic Evaluation of 7‐Deazapurine‐Based Neplanocin Analogues as Selective Anti‐HBV Agents. ChemistrySelect 2025; 10(22) doi: 10.1002/slct.202500784
|
| 2 |
Bai-Hua Zhang, Yuanping Zhou, Stephen Horrigan, Laura Luckenbaugh, Jianming Hu, Fabien Zoulim, Yong-Yuan Zhang. HBVZ10, an AAV8 vector-based new HBV therapy candidate for cccDNA elimination. Molecular Therapy Methods & Clinical Development 2025; 33(4): 101646 doi: 10.1016/j.omtm.2025.101646
|
| 3 |
Chiara Rubino, Mariangela Stinco, Giuseppe Indolfi. Hepatitis co-infection in paediatric HIV: progressing treatment and prevention. Current Opinion in HIV and AIDS 2024; 19(6): 338 doi: 10.1097/COH.0000000000000882
|
| 4 |
Javiera Cortés‐Ríos, Tianjing Ren, Nathan Hanan, Anna Sher, Ahmed Nader, Mindy Magee, William J. Jusko, Rajat Desikan. Hepatitis B In Silico Trials Capture Functional Cure, Indicate Mechanistic Pathways, and Suggest Prognostic Biomarker Signatures. Clinical Pharmacology & Therapeutics 2025; 118(3): 600 doi: 10.1002/cpt.3718
|
| 5 |
Simon P. Fletcher, Rudolf K. Beran. Understanding and Targeting HBV Transcription and Post-Transcriptional Regulation. Viruses 2024; 16(11): 1793 doi: 10.3390/v16111793
|
| 6 |
Juntian Yao, Jinsheng Guo, Youhua Xie. Hepatitis B virus induced cirrhosis and hepatocarcinoma: pathogenesis and therapeutics. Exploration of Digestive Diseases 2025; doi: 10.37349/edd.2025.100565
|
| 7 |
Mitchell Leus, Chukwunomso E Osakwe, Danjuma Adda, Manal El-Sayed, Jessica Hicks, Yasmin Ibrahim, Philippa C Matthews, Nicaise Ndembi, Theobald Owusu-Ansah, Catherine Wendy Spearman, Mark W Sonderup, John Ward, Robin Schaefer, Veronica Miller. Strengthening hepatitis B virus clinical research in Africa: the need for multistakeholder collaboration, funding, and political will. The Lancet Microbe 2026; 7(1): 101266 doi: 10.1016/j.lanmic.2025.101266
|
| 8 |
Mamun Al Mahtab, Julio CA Rubido, Gerardo E Guillén, Eduardo Penton, Osamu Yoshida, Yoichi Hiasa, Sakirul Khan, Md Abdur Rahim, Noor-E-Alam Mohammad, Ahmed L Moben, Rokshana Begum, Musarrat Mahtab, Sheikh MF Akbar. The Sustainable Goal of Eliminating Hepatitis B, Functional Cure, and the Prospect of NASVAC: A Review. Euroasian journal of hepato-gastroenterology 2026; 15(2): 178 doi: 10.5005/jp-journals-10018-1483
|